Chlorpromazine 50 mg tablets recalled over nitrosamine above recommended intake limit
Major Pharmaceuticals is recalling 506 blister packs of Chlorpromazine Hydrochloride Tablets USP 50 mg because N-Nitroso Desmethyl Chlorpromazine was present above the recommended intake limit.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: Scored 3 under the risk-of-harm criterion: a named nitrosamine impurity exceeding its recommended intake limit is a defined safety threshold breach, with no injuries reported.
Plain-English summary
Major ChlorproMAZINE Hydrochloride Tablets, USP, 50 mg, in 100-tablet (10x10) blister packages, packaged and distributed by Major Pharmaceuticals of Indianapolis, Indiana, are being recalled for CGMP deviations: the presence of N-Nitroso Desmethyl Chlorpromazine above the recommended intake limit.
The recall covers 506 blister packs carrying NDC 0904-7131-61, from lots N02009 and N02026, expiring 28 February 2026. The product was distributed nationwide. The FDA has classified the recall as Class II.
The enforcement record identifies the nitrosamine impurity and the exceeded intake limit, and reports no injuries.
Chlorpromazine is a prescription medicine, so patients holding the affected lots should contact their pharmacy or prescriber about a replacement rather than stopping treatment on their own.
The recalled product
- Product
- CHLORPROMAZINE HYDROCHLORIDE (CHLORPROMAZINE HYDROCHLORIDE)
- Brand
- CHLORPROMAZINE HYDROCHLORIDE
- Manufacturer
- The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories
- Category
- Drug — Antipsychotic
- Hazard
- nitrosamine
- impurity
- cgmp-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lots N02009 & N02026
- exp. date 02/28/2026
UPCs (1)
- 003090471316
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · CHLORPROMAZINE HYDROCHLORIDE
- HighChlorpromazine 25 mg tablets recalled over nitrosamine above recommended intake limit
FDA (Drugs) · 2025-10-15
- HighChlorpromazine 25 mg fifty count packs recalled over nitrosamine impurity
FDA (Drugs) · 2025-10-15
- HighChlorpromazine 200 mg tablets recalled over nitrosamine above recommended intake limit
FDA (Drugs) · 2025-10-15
- HighChlorpromazine tablets recalled over nitrosamine impurity above recommended intake limit
FDA (Drugs) · 2025-10-15
- ModerateChlorpromazine 25 mg blisterpacks recalled over micro-organism on packaging coil
FDA (Drugs) · 2025-09-24
Same category
- SevereCleviprex Injectable Emulsion Recall Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-07-22
- ModerateQuality Choice Earwax Removal Kit Carbamide Peroxide Subpotent Drug Recall
FDA (Drugs) · 2026-07-22
- ModerateFamily Wellness Carbamide Peroxide Earwax Removal Kit Subpotent Drug
FDA (Drugs) · 2026-07-22
- ModerateLeader Carbamide Peroxide Earwax Removal Kit Recalled for Subpotency
FDA (Drugs) · 2026-07-22
- ModerateNystatin Cream Recall Due to Low Potency Test Results
FDA (Drugs) · 2026-07-22